B

BioNote Inc
KRX:377740

Watchlist Manager
BioNote Inc
KRX:377740
Watchlist
Price: 4 600 KRW -2.13% Market Closed
Market Cap: 469.1B KRW
Have any thoughts about
BioNote Inc?
Write Note

BioNote Inc
Accounts Receivables

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

BioNote Inc
Accounts Receivables Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Accounts Receivables CAGR 3Y CAGR 5Y CAGR 10Y
B
BioNote Inc
KRX:377740
Accounts Receivables
â‚©24B
CAGR 3-Years
-57%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Celltrion Inc
KRX:068270
Accounts Receivables
â‚©963.2B
CAGR 3-Years
-8%
CAGR 5-Years
3%
CAGR 10-Years
8%
SK Bioscience Co Ltd
KRX:302440
Accounts Receivables
â‚©18.2B
CAGR 3-Years
-17%
CAGR 5-Years
-16%
CAGR 10-Years
N/A
H
Hugel Inc
KOSDAQ:145020
Accounts Receivables
â‚©45.8B
CAGR 3-Years
18%
CAGR 5-Years
3%
CAGR 10-Years
N/A
P
PharmaResearch Co Ltd
KOSDAQ:214450
Accounts Receivables
â‚©32.9B
CAGR 3-Years
7%
CAGR 5-Years
12%
CAGR 10-Years
N/A
Alteogen Inc
KOSDAQ:196170
Accounts Receivables
â‚©10B
CAGR 3-Years
48%
CAGR 5-Years
16%
CAGR 10-Years
N/A
No Stocks Found

BioNote Inc
Glance View

Market Cap
469.5B KRW
Industry
Biotechnology

BioNote, Inc. develops veterinary diagnostic composition. The company is headquartered in Hwaseong, Gyeonggi-Do. The company went IPO on 2022-12-22. The firm is engaged in the manufacture and sale of rapid diagnostic kits for humans, diagnosis raw materials such as antigens, antibody cell lines, standards, enzymes and others as well as semi-finished products. The firm is also engaged in the manufacture and sale of rapid immunochemical diagnosis, enzyme immune rebound protein, immunochemical fluorescence diagnosis and other products used for animals.

Intrinsic Value
6 138.02 KRW
Undervaluation 25%
Intrinsic Value
Price
B

See Also

What is BioNote Inc's Accounts Receivables?
Accounts Receivables
24B KRW

Based on the financial report for Dec 31, 2023, BioNote Inc's Accounts Receivables amounts to 24B KRW.

What is BioNote Inc's Accounts Receivables growth rate?
Accounts Receivables CAGR 3Y
-57%

Over the last year, the Accounts Receivables growth was 34%. The average annual Accounts Receivables growth rates for BioNote Inc have been -57% over the past three years .

Back to Top